Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +49.94%
#3 Velvet Velvet +41.51%
#4 Black Phoenix Black Phoenix +34.92%
#5 Palladium Network Palladium Network +21.70%
#6 DoubleZero DoubleZero +20.39%
#7 Akedo Akedo +19.80%
#8 Fake World Assets Fake World Assets +19.72%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.14%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.99%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
C4X Discovery Holdings plc C4X Discovery Holdings plc

C4X Discovery Holdings plc

C4XD
Clasificación en acciones #39626
C4X Discovery Holdings plc is a pharmaceutical research firm based in... C4X Discovery Holdings plc is a pharmaceutical research firm based in Manchester, United Kingdom, specializing in the discovery of new drugs. The company leverages advanced proprietary technologies for drug discovery, including Taxonomy3, an innovative computational platform employing unique mathematical algorithms to conduct intricate multi-variable analysis of genetic information. Additionally, Conformetrix provides a technology to precisely determine the three-dimensional structures of unbound drug molecules using experimental data, furnishing medicinal chemists with unparalleled understanding of their physical characteristics and how they behave. Its 4Sight tool further enables the visualization of four-dimensional molecules within a virtual reality environment. The company's development pipeline features several promising candidates: an Orexin-1 receptor antagonist aimed at addictive disorders; an NRF-2 activator targeting various inflammatory conditions; an IL-17A inhibitor for inflammation and autoimmune responses; α4β7 integrin inhibitors developed for inflammatory bowel disease; and MALT-1 inhibitors designed to combat hematological cancers. C4X Discovery has established significant collaborations with key industry players such as Sanofi, GEN-COVID, LifeArc, Indivior PLC, Phoremost, AstraZeneca UK Limited, and Evotec SE. Established in 2007, the company initially traded as Schosween 24 plc before adopting its current name, C4X Discovery Holdings plc, in October 2014.
Precio por acción
$0.16328419
Última sincronización: 2024-04-25
Capitalización bursátil
$411.85K
Cambio (1 día)
38.98%
Cambio (1 año)
0.00%
País
GB
Comercio C4X Discovery Holdings plc (C4XD)

Categoría

Healthcare
Ganancias de C4X Discovery Holdings plc (C4XD)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di C4X Discovery Holdings plc, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de C4X Discovery Holdings plc desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE